Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0739-2020Class II

7% BSA (Bovine Serum Albumin)

Ortho-Clinical Diagnostics, Inc. / initiated 2019-10-14 / Terminated / root cause: design

Ortho Clinical Diagnostics Inc began a recall of 7% BSA (Bovine Serum Albumin), Product Code: 8262487 - Product Usage: is used to dilute samples when assay values exceed the reportable (dynamic) range using... on . FDA classified it as Class II and gives the reason as "Potential for the instability of the diluents VITROS 7% BSA (Product Code 8262487) and VITROS Urine Electrolyte Diluent (UED) (Product Code 1110352) when stored in a 2mL cup for 7 days". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-0739-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Ortho-Clinical Diagnostics, Inc.
Product
7% BSA (Bovine Serum Albumin), Product Code: 8262487 - Product Usage: is used to dilute samples when assay values exceed the reportable (dynamic) range using the VITROS 250/350/5,1 FS/4600 Chemistry Systems and VITROS 5600/XT 7600 Integrated Systems.
Product code
DCF Albumin, Antigen, Antiserum, Control
Reason for recall
Potential for the instability of the diluents VITROS 7% BSA (Product Code 8262487) and VITROS Urine Electrolyte Diluent (UED) (Product Code 1110352) when stored in a 2mL cup for 7 days
Root cause tag
design
FDA root cause
Device Design
Action
On August 9, 2019 the firm distributed Urgent Medical Device Recall Communication letters by via FedEx overnight courier and/ or ORTHO PLUS e-Communications and/ or US Postal Service Priority Mail (for PO Boxes only) summarizing the reason as Ortho Clinical Diagnostics determined that VITROS 7% BSA and VITROS Urine Electrolyte Diluent (UED) do not meet the current OAS time of d 7 days when stored on the VITROS 250/350 System in a 2mL cup only. Orthos internal testing compared results from samples diluted with diluent stored on the analyzer versus fresh diluent. When using 7% BSA or UED stored in a 2mL cup for 7 days, the differences in the results vs fresh diluent were >10% for some assays. It explained as a resolution: " The OAS of 7% BSA and UED in 2mL cups has been revised to d24 hours. " Current OAS time remains at d7 days for storage in 5mL and 10 mL bottles. " The Instructions for Use and appropriate User Documentation will be revised at a future date. It instructs them to: - Send the enclosed customer letter to all customers to whom you shipped or know to have a VITROS 250/350 System. Please continue to provide this letter to new customers until the Instructions for Use are updated. - Complete and return the Confirmation of Receipt form by October 22, 2019.
Quantity in commerce
16,584
Distribution
Worldwide distribution - US Nationwide distribution and countries BM, AU, BR, CA, CL, CN, CO, IN, JP, MX, SG, GB, FR, DE, IT, ES, PT, PL, RU, DK, NO, SE, BE, NL.
Product codes and lots
Lot with Expiry Date: D6289 2019-11-20 E6382 2020-01-15 F6602 2020-05-02 G6679 2020-08-13 H6897 2020-10-01 J7129 2021-01-23 K7421 2021-07-01 L7592 2021-08-26

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0739-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0739-2020Class IITerminatedVoluntary: Firm initiated
Z-0740-2020Class IITerminatedVoluntary: Firm initiated